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Dear Editor,
People with co-morbidities such as tuberculosis (TB) or other
chronic lung disease are at increased risk of severe COVID-19, including
requirement for intensive care and mechanical ventilation.[1] The
Philippines has a high burden of TB with around 1 million active cases.
[2] However, little is known about the current situation regarding novel
coronavirus (SARS–CoV-2) infection among TB patients in the Phi-
lippines. In this brief report, we share our experience of screening
healthcare workers and patients on the TB ward at San Lazaro Hospital
(SLH), the national referral hospital for infectious diseases located in
Manila, the Philippines.
SLH is a public hospital serving a large urban poor population with a
large TB ward and high admission rates of TB patients.[3] However, the
number of inpatients reduced from 107 in January 15, 2020 to 35 in
April 23, 2020 primarily due to 2 reasons – fear of contracting COVID-
19 in SLH, and the inability to enter Manila for hospital consults due to
the enhanced community quarantine, which began on March 17. The
first confirmed cases of COVID-19 were managed at SLH in late January
2020.[4] A further 33 confirmed COVID-19 patients were managed
from February to March 30. COVID-19 polymerase chain reaction (PCR)
testing was established in the Philippines at the Research Institute of
Tropical Medicine (the national reference laboratory) in February 2020.
[5] Testing was initially limited to people with exposure history and
symptoms. COVID-19 PCR testing was established at the SLH laboratory
on March 22, in order to increase testing capacity at SLH and enable
screening of healthcare workers.
From March 22 to April 23, 309 healthcare workers reporting either
symptoms or exposure were referred from the infection control de-
partment and screened. Through this screening, we identified seven
COVID-19 infections in healthcare workers, including two nurses
working on the TB ward. On March 21, one of the doctors working on
the TB ward tested positive for COVID-19. He had developed mild
symptoms three days prior and had been in contact with patients and
other healthcare workers. These three infections led to concern of a
possible infection cluster on the TB ward and significant anxiety
amongst fellow healthcare workers. We decided to screen healthcare
workers who had been in contact with the doctor, as well as all of the
staff and patients on the TB ward to look for any evidence of nosoco-
mial transmission.
Nasopharyngeal and oropharyngeal swabs were taken from all of
the 26 admitted TB patients and 40 healthcare workers of whom six had
mild respiratory symptoms. The specimens all tested negative for SARS-
2CoV by real-time reverse transcriptase polymerase chain reaction
(qRT-PCR). Although it is possible that false negatives may have oc-
curred as a result of timing and method of sample collection, overall the
identification of no additional infections was reassuring for the
healthcare workers and they felt more confident to continue their duties
under challenging conditions, concerned about risk of both TB and
COVID-19 infection.
At the present time, we foresee two challenges. First, how to reduce
the risk of COVID-19 infection on the TB ward. In addition to standard
infection control practices, we feel that enhanced screening of patients
will enable prompt detection of a cluster to enable early isolation of
cases. Screening of healthcare workers provides reassurance in the case
of negative tests. The second challenge relates to maintaining high-
quality uninterrupted TB care. Inpatient numbers have fallen and part
of the reason may be that patients want to avoid hospitals where
COVID-19 patients are treated. In this case, patients need to be ade-
quately followed up and feel confident to be admitted to hospital if
required.
In conclusion, it is reassuring that at this time, we found no evidence
of a COVID-19 infection cluster on the TB ward at San Lazaro Hospital.
However, as the number of cases continued to increase in the
Philippines, continued vigilance is required.
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